mesothelioma
Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.
Response to the methylation inhibitor dihydro-5-azacytidine in <span class="disease" id="18379362-0-63-75">mesothelioma</span> is not associated with methylation of <span class="gene" id="18379362-0-114-122">p16INK4a</span>: results of cancer and leukemia group B 159904.